Dianthus Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 412.4% | 412.4% | -37.5% |
| FY2022 | 64.2% | 64.2% | -34.3% |
| FY2023 | -25.8% | -25.8% | -24.3% |
| FY2024 | -24.1% | -24.1% | -22.7% |
| FY2025 | -32.9% | -32.9% | -30.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 412.4% | 412.4% | -37.5% |
| FY2022 | 64.2% | 64.2% | -34.3% |
| FY2023 | -25.8% | -25.8% | -24.3% |
| FY2024 | -24.1% | -24.1% | -22.7% |
| FY2025 | -32.9% | -32.9% | -30.6% |